Publicação: Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria
dc.contributor.author | Scarim, Cauê Benito [UNESP] | |
dc.contributor.author | Jornada, Daniela Hartmann [UNESP] | |
dc.contributor.author | Machado, Marcella Gabrielle Mendes [UNESP] | |
dc.contributor.author | Ferreira, Carla Maria Riberio [UNESP] | |
dc.contributor.author | dos Santos, Jean Leandro [UNESP] | |
dc.contributor.author | Chung, Man Chin [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2019-10-06T15:24:45Z | |
dc.date.available | 2019-10-06T15:24:45Z | |
dc.date.issued | 2019-01-15 | |
dc.description.abstract | Thiazole, thiosemicarbazone and semicarbazone moieties are privileged scaffolds (acting as primary pharmacophores) in many compounds that are useful to treat several diseases, mainly tropical infectious diseases. In this review article, we critically analyzed the contribution of these scaffolds to medicinal chemistry in the last five years, focusing on tropical infectious diseases, such as Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria. We also present perspectives for their use in drug design in order to contribute to the development of new drugs. | en |
dc.description.affiliation | São Paulo State University (UNESP) School of Pharmaceutical Sciences | |
dc.description.affiliationUnesp | São Paulo State University (UNESP) School of Pharmaceutical Sciences | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorshipId | FAPESP: FAPESP - 2016/10847-9 | |
dc.format.extent | 378-395 | |
dc.identifier | http://dx.doi.org/10.1016/j.ejmech.2018.11.013 | |
dc.identifier.citation | European Journal of Medicinal Chemistry, v. 162, p. 378-395. | |
dc.identifier.doi | 10.1016/j.ejmech.2018.11.013 | |
dc.identifier.issn | 1768-3254 | |
dc.identifier.issn | 0223-5234 | |
dc.identifier.lattes | 9734333607975413 | |
dc.identifier.orcid | 0000-0003-4141-0455 | |
dc.identifier.scopus | 2-s2.0-85056663289 | |
dc.identifier.uri | http://hdl.handle.net/11449/187074 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Journal of Medicinal Chemistry | |
dc.rights.accessRights | Acesso aberto | pt |
dc.source | Scopus | |
dc.subject | Chagas disease | |
dc.subject | Drug development | |
dc.subject | New drugs | |
dc.subject | Semicarbazone | |
dc.subject | T. cruzi | |
dc.subject | Thiazole | |
dc.subject | Thiosemicarbazone | |
dc.title | Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria | en |
dc.type | Resenha | pt |
dspace.entity.type | Publication | |
relation.isOrgUnitOfPublication | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
relation.isOrgUnitOfPublication.latestForDiscovery | 95697b0b-8977-4af6-88d5-c29c80b5ee92 | |
unesp.author.lattes | 9734333607975413[6] | |
unesp.author.orcid | 0000-0003-4141-0455[6] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquara | pt |